Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 681,523 |
|
|||||
| News | (1) | ||||||
| Day High | 0.7619 | Low High |
|||||
| Day Low | 0.7111 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Spruce Biosciences Inc | SPRB | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.0255 | -3.40% | 0.7256 | 16:16:35 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.7451 | 0.7111 | 0.7619 | 0.7256 | 0.7511 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,402 | 681,523 | $ 0.7379523 | $ 502,931 | - | 0.6711 - 5.95 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:43:28 | 1 | $ 0.7257 | USD |
Spruce Biosciences Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 29.72M | 40.71M | - | 10.09M | -47.92M | -1.18 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Spruce Biosciences News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SPRB Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.781 | 0.80 | 0.7111 | 0.7590231 | 420,596 | -0.0554 | -7.09% |
| 1 Month | 0.6802 | 0.87 | 0.6802 | 0.7741353 | 451,007 | 0.0454 | 6.67% |
| 3 Months | 5.37 | 5.95 | 0.6711 | 1.16 | 1,398,458 | -4.64 | -86.49% |
| 6 Months | 1.32 | 5.95 | 0.6711 | 1.59 | 819,264 | -0.5944 | -45.03% |
| 1 Year | 2.52 | 5.95 | 0.6711 | 1.63 | 458,405 | -1.79 | -71.21% |
| 3 Years | 15.06 | 15.08 | 0.6711 | 3.29 | 655,306 | -14.33 | -95.18% |
| 5 Years | 17.00 | 35.60 | 0.6711 | 3.69 | 557,468 | -16.27 | -95.73% |
Spruce Biosciences Description
| Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders. The company is developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy to offer improved disease control and reduce steroid burden for patients suffering from classic congenital adrenal hyperplasia (CAH). |
